Ironwood Pharmaceuticals Company Profile (NASDAQ:IRWD)

About Ironwood Pharmaceuticals

Ironwood Pharmaceuticals logoIronwood Pharmaceuticals, Inc. is a biotechnology company. The Company's products Linaclotide provides patients and healthcare practitioners with a treatment option for adults in the United States and certain other countries with irritable bowel syndrome with constipation (IBS-C), chronic idiopathic constipation (CIC) and gastrointestinal (GI) disorders. It operates through human therapeutics segment. Linaclotide is also being developed and commercialized in other parts of the world by certain of its partners. It is engaged in developing therapeutic platforms for the treatment of vascular and fibrotic diseases, and refractory gastroesophageal reflux disease (GERD). Its IW-9179 is used for the treatment of gastroparesis and functional dyspepsia. The Company has conducted an exploratory Phase IIa clinical study of IW-3718 in patients with refractory GERD. It has two sGC development candidates, which include IW-1973 and IW-1701.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: IRWD
  • CUSIP: 46333X10
Key Metrics:
  • Previous Close: $13.50
  • 50 Day Moving Average: $13.57
  • 200 Day Moving Average: $11.68
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -31.40
  • P/E Growth: -0.46
  • Market Cap: $1.96B
  • Outstanding Shares: 145,318,000
  • Beta: 1.64
Additional Links:
Companies Related to Ironwood Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Ironwood Pharmaceuticals (NASDAQ:IRWD) (?)
Ratings Breakdown: 5 Hold Ratings, 6 Buy Ratings
Consensus Rating:Buy (Score: 2.55)
Consensus Price Target: $15.11 (11.93% upside)

Analysts' Ratings History for Ironwood Pharmaceuticals (NASDAQ:IRWD)
DateFirmActionRatingPrice TargetDetails
8/8/2016Leerink SwannReiterated RatingMarket Perform$10.00 -> $14.00View Rating Details
8/5/2016JPMorgan Chase & Co.Boost Price TargetOverweight$15.00 -> $16.00View Rating Details
8/5/2016Barclays PLCBoost Price TargetEqual Weight$11.00 -> $12.00View Rating Details
8/4/2016WedbushReiterated RatingNeutral$10.00View Rating Details
7/15/2016MizuhoBoost Price TargetBuy$16.00 -> $24.00View Rating Details
5/26/2016Cowen and CompanyReiterated RatingBuyView Rating Details
4/28/2016JP Morgan CazenoveReiterated RatingOverweight$15.00View Rating Details
4/26/2016Morgan StanleyReiterated RatingHoldView Rating Details
3/23/2016Wood & CompanyInitiated CoveragePositiveView Rating Details
3/21/2016Goldman Sachs Group Inc.Initiated CoverageNeutral$14.00View Rating Details
2/20/2016BTIG ResearchReiterated RatingBuy$15.00View Rating Details
5/1/2015Cantor FitzgeraldReiterated RatingHold$13.50View Rating Details
4/27/2015Bank of America Corp.Initiated CoverageBuy$19.00View Rating Details
2/13/2015WallachBeth CapitalBoost Price TargetHold$15.00 -> $17.00View Rating Details
(Data available from 8/24/2014 forward)


Earnings History for Ironwood Pharmaceuticals (NASDAQ:IRWD)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/4/2016Q216($0.15)($0.16)$54.49 million$54.40 millionViewN/AView Earnings Details
5/9/2016Q116($0.14)($0.08)$52.97 million$66.00 millionViewN/AView Earnings Details
2/18/2016Q415($0.17)($0.10)$44.78 million$53.30 millionViewListenView Earnings Details
11/3/2015Q315($0.20)($0.25)$39.81 million$39.60 millionViewListenView Earnings Details
8/5/2015Q215($0.22)($0.34)$36.08 million$27.74 millionViewN/AView Earnings Details
5/5/2015Q115($0.23)($0.24)$32.30 million$28.90 millionViewN/AView Earnings Details
2/12/2015Q414($0.21)($0.27)$35.20 million$38.10 millionViewListenView Earnings Details
11/4/2014Q314($0.32)($0.30)$21.20 million$16.90 millionViewListenView Earnings Details
8/4/2014Q214($0.36)($0.38)$15.75 million$6.84 millionViewListenView Earnings Details
4/29/2014Q1($0.44)($0.38)$8.52 million$14.60 millionViewListenView Earnings Details
1/21/2014Q413($0.50)($0.43)$7.13 million$5.00 millionViewListenView Earnings Details
10/22/2013Q313($0.57)($0.51)$6.54 million$4.90 millionViewN/AView Earnings Details
7/23/2013Q2 2013($0.70)($0.57)$6.32 million$9.70 millionViewN/AView Earnings Details
4/23/2013Q1 2013($0.71)($0.87)$8.94 million$3.30 millionViewN/AView Earnings Details
1/15/2013Q4 2012($0.49)($0.41)$16.17 million$27.00 millionViewN/AView Earnings Details
10/16/2012$0.17$0.42ViewN/AView Earnings Details
7/17/2012($0.31)($0.38)ViewN/AView Earnings Details
5/1/2012($0.23)($0.34)ViewN/AView Earnings Details
2/28/2012($0.11)($0.07)ViewN/AView Earnings Details
11/7/2011($0.20)($0.21)ViewN/AView Earnings Details
8/11/2011($0.18)($0.19)ViewN/AView Earnings Details
5/12/2011($0.17)($0.19)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Ironwood Pharmaceuticals (NASDAQ:IRWD)
Current Year EPS Consensus Estimate: $-0.76 EPS
Next Year EPS Consensus Estimate: $-0.43 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.16)($0.08)($0.11)
Q2 20162($0.13)($0.12)($0.13)
Q3 20162($0.17)($0.16)($0.17)
Q4 20162($0.20)($0.16)($0.18)
Q1 20171($0.15)($0.15)($0.15)
Q2 20171($0.09)($0.09)($0.09)
Q3 20171($0.02)($0.02)($0.02)
Q4 20171$0.04$0.04$0.04
(Data provided by Zacks Investment Research)


Dividend History for Ironwood Pharmaceuticals (NASDAQ:IRWD)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Ironwood Pharmaceuticals (NASDAQ:IRWD)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/19/2016Gina ConsylmanInsiderSell207$13.54$2,802.78View SEC Filing  
6/3/2016Lawrence S OlanoffDirectorSell2,200$12.92$28,424.00View SEC Filing  
5/25/2016Halley E GilbertInsiderSell20,275$12.19$247,152.25View SEC Filing  
3/11/2016Peter M HechtCEOSell120,000$10.72$1,286,400.00View SEC Filing  
3/7/2016Lawrence S OlanoffDirectorSell2,200$11.11$24,442.00View SEC Filing  
2/24/2016Edward P OwensDirectorBuy10,000$8.32$83,200.00View SEC Filing  
2/24/2016Gina ConsylmanCAOSell420$8.50$3,570.00View SEC Filing  
2/24/2016Mark G CurrieInsiderSell152,154$8.53$1,297,873.62View SEC Filing  
2/24/2016Thomas GraneyCFOSell563$8.50$4,785.50View SEC Filing  
12/15/2015Peter M. HechtCEOSell73,418$11.07$812,737.26View SEC Filing  
12/7/2015Lawrence S OlanoffDirectorSell2,200$11.77$25,894.00View SEC Filing  
9/4/2015Lawrence S OlanoffDirectorSell3,725$10.97$40,863.25View SEC Filing  
3/17/2015Peter M HechtCEOSell200,000$15.62$3,124,000.00View SEC Filing  
3/12/2015Joseph C Cook JrDirectorSell5,883$15.54$91,421.82View SEC Filing  
3/10/2015Bryan E RobertsDirectorSell95,998$15.20$1,459,169.60View SEC Filing  
3/3/2015Peter M HechtCEOSell63,442$15.75$999,211.50View SEC Filing  
2/20/2015Joseph C Cook JrDirectorSell35,500$15.60$553,800.00View SEC Filing  
12/15/2014Bryan E RobertsDirectorSell19,792$15.20$300,838.40View SEC Filing  
6/12/2014Bryan E RobertsDirectorSell200,000$14.24$2,848,000.00View SEC Filing  
5/29/2014Michael J HigginsCOOSell50,000$14.56$728,000.00View SEC Filing  
5/22/2014Mark CurrieInsiderSell25,000$13.93$348,250.00View SEC Filing  
4/24/2014Mark CurrieInsiderSell25,000$11.67$291,750.00View SEC Filing  
1/23/2014Mark CurrieInsiderSell20,000$14.38$287,600.00View SEC Filing  
1/14/2014Bryan RobertsDirectorSell21,200$12.57$266,484.00View SEC Filing  
1/13/2014Bryan RobertsDirectorSell823,350$12.71$10,464,778.50View SEC Filing  
1/6/2014Bryan RobertsDirectorSell55,450$12.01$665,954.50View SEC Filing  
11/7/2013Terrance McguireDirectorSell2,083$9.11$18,976.13View SEC Filing  
6/17/2013Michael J HigginsCOOSell150,000$11.74$1,761,000.00View SEC Filing  
3/11/2013Thomas A MccourtInsiderSell40,000$17.00$680,000.00View SEC Filing  
11/5/2012Peter M HechtCEOBuy50,000$11.65$582,500.00View SEC Filing  
10/8/2012Fmr LlcInsiderSell19,305$13.02$251,351.10View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Ironwood Pharmaceuticals (NASDAQ:IRWD)
DateHeadline logoIRONWOOD PHARMACEUTICALS INC Financials (NASDAQ:IRWD) - August 17 at 5:53 PM
News IconActive Movers: Ironwood Pharmaceuticals, Inc.(NASDAQ:IRWD), Cempra Inc (NASDAQ:CEMP) - NYSE Journal (press release) (NASDAQ:IRWD) - August 17 at 8:47 AM
News IconNotable Stocks To Track: American Woodmark Corporation (NASDAQ:AMWD), Ironwood Pharmaceuticals, Inc ... - NYSE Journal (press release) (NASDAQ:IRWD) - August 15 at 3:49 PM logoETF’s with exposure to Ironwood Pharmaceuticals, Inc. : August 10, 2016 (NASDAQ:IRWD) - August 10 at 5:59 PM logoIronwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:IRWD) - August 9 at 5:54 PM logoIronwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : August 9, 2016 (NASDAQ:IRWD) - August 9 at 8:45 AM logoIRONWOOD PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report (NASDAQ:IRWD) - August 8 at 5:55 PM logoIronwood reports 2Q loss (NASDAQ:IRWD) - August 5 at 8:43 AM logoEdited Transcript of IRWD earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:IRWD) - August 5 at 8:43 AM logoIronwood Pharmaceuticals Provides Second Quarter 2016 Investor Update (NASDAQ:IRWD) - August 4 at 5:59 PM logo4:35 pm Ironwood Pharma reports EPS in-line, revs in-line (NASDAQ:IRWD) - August 4 at 5:59 PM logoQ2 2016 Ironwood Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:IRWD) - August 4 at 8:44 AM logoWhy Ironwood Pharmaceuticals (IRWD) Might Surprise This Earnings Season - Nasdaq (NASDAQ:IRWD) - August 3 at 6:00 PM logoWhy Ironwood Pharmaceuticals (IRWD) Might Surprise This Earnings Season (NASDAQ:IRWD) - August 3 at 6:00 PM
News IconThe Key Numbers To Watch From Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)'s Earnings - The Voice Registrar (NASDAQ:IRWD) - August 1 at 5:34 PM logoIronwood Pharmaceuticals Inc. (IRWD) Hits New 52-week High During July 28 Session - (NASDAQ:IRWD) - July 30 at 8:36 AM logoWhat's in Store for Prothena (PRTA) This Earnings Season? (NASDAQ:IRWD) - July 29 at 5:53 PM logoIronwood Pharmaceuticals Inc. (IRWD) Hits New 52-week High During July 26 Session - (NASDAQ:IRWD) - July 28 at 8:45 AM logoLast Analysts Rating Review: Sophiris Bio, Inc. (NASDAQ:SPHS) , Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Street Updates (NASDAQ:IRWD) - July 26 at 8:39 AM
News IconIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily (NASDAQ:IRWD) - July 23 at 9:41 AM logoIronwood Pharmaceuticals Inc. (IRWD) Hits New 52-week High During July 21 Session - (NASDAQ:IRWD) - July 23 at 9:41 AM logoRecent Analysts Rating Overview: Eli Lilly and Company (NYSE:LLY) , Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Street Updates (NASDAQ:IRWD) - July 21 at 5:52 PM logoIronwood Pharmaceuticals to Host Second Quarter 2016 Investor Update Call (NASDAQ:IRWD) - July 21 at 4:01 PM
News IconShares Positive Over the Past Month: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - TGP (NASDAQ:IRWD) - July 20 at 3:43 PM logoIronwood Pharmaceuticals Inc. (IRWD) Hits New 52-week High During July 18 Session - (NASDAQ:IRWD) - July 20 at 8:42 AM
News IconEquity Roundup: Stock Performance Focus on Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Press Telegraph (NASDAQ:IRWD) - July 20 at 8:42 AM logoIronwood Pharmaceuticals Inc. (IRWD) Broke Out To A New High For The Year (NASDAQ:IRWD) - July 19 at 5:47 PM
News IconShares of Ironwood Pharmaceuticals (IRWD) Rally 1.8% - TheFounders Daily (NASDAQ:IRWD) - July 18 at 5:52 PM logoWill Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Surprise Analysts? - Investor Newswire (NASDAQ:IRWD) - July 16 at 5:25 PM
News IconShares Experiencing a Downtrend: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - TGP (NASDAQ:IRWD) - July 16 at 9:03 AM
News IconPerformance report of the company: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - News Oracle (NASDAQ:IRWD) - July 16 at 9:03 AM logoIronwood Pharmaceuticals Inc. (IRWD) Jumps 8.45% on July 15 - (NASDAQ:IRWD) - July 16 at 9:03 AM
News IconIncreased Volatility Noted on Shares of: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Engelwood Daily (NASDAQ:IRWD) - July 15 at 4:44 PM
News IconIronwood Pharmaceuticals Class A (NASDAQ:IRWD) Short Interest Decreased By 4.36% - Consumer Eagle (NASDAQ:IRWD) - July 15 at 9:29 AM
News IconIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:IRWD) - July 15 at 9:29 AM logoIronwood Pharmaceuticals Inc. (IRWD) is Trading Lower on Unusual Volume for July 12 - (NASDAQ:IRWD) - July 14 at 5:53 PM logoShort Term Rating on Ironwood Pharmaceuticals (IRWD) - Trade Calls (NASDAQ:IRWD) - July 13 at 8:36 AM
News IconStock on the Rise for the Quarter: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Engelwood Daily (NASDAQ:IRWD) - July 12 at 10:03 AM
News IconIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Wall Street Analyst Recommendation Outlook - Telanagana Press (NASDAQ:IRWD) - July 12 at 10:03 AM logoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Updated Price Targets - FTSE News (NASDAQ:IRWD) - July 12 at 10:03 AM logoHave a look at Analyst Actions: Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) , Endologix, Inc. (NASDAQ:ELGX) - Street Updates (NASDAQ:IRWD) - July 12 at 10:03 AM
News IconCoverage Initiated on Select Generic Drugs Makers Equities (NASDAQ:IRWD) - July 12 at 9:28 AM
News IconBvf INC Decreased Stake in Ironwood Pharmaceuticals INC (NASDAQ:IRWD) by $11.80 Million as Shares Declined - Press Telegraph (NASDAQ:IRWD) - July 9 at 9:04 AM logoIronwood Pharmaceuticals Inc. (IRWD) Hits New 52-week High During July 07 Session - (NASDAQ:IRWD) - July 9 at 9:04 AM
News IconInsiders are Gradually Selling Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Telanagana Press (NASDAQ:IRWD) - July 7 at 8:35 AM
News Icon1.24 is Ironwood Pharmaceuticals Inc's (NASDAQ:IRWD) Institutional Investor Sentiment - Engelwood Daily (NASDAQ:IRWD) - July 7 at 8:35 AM logoBroker Outlook For Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Fiscal Standard (NASDAQ:IRWD) - July 7 at 8:35 AM
News IconEcor1 Capital LLC Increased Ironwood Pharmaceuticals INC (NASDAQ:IRWD) by $12.40 Million as Shares Declined - Press Telegraph (NASDAQ:IRWD) - July 2 at 8:37 AM
News IconIronwood Pharmaceuticals Class A (NASDAQ:IRWD) Sellers Covered 4.36% of Their Shorts - Engelwood Daily (NASDAQ:IRWD) - July 1 at 8:29 AM logoRecently Issued Stock Ratings For Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Fiscal Standard (NASDAQ:IRWD) - July 1 at 8:29 AM


Ironwood Pharmaceuticals (NASDAQ:IRWD) Chart for Wednesday, August, 24, 2016

Last Updated on 8/24/2016 by Staff